A Study of ALXN1840 (Coated and Non-coated) Administered With And Without Omeprazole In Healthy Adults
Study Identifier:
WTX101-102
ClinicalTrials.gov Identifier:
EudraCT Identifier:
N/A
Sponsor:
Alexion Pharmaceuticals, Inc.
Study Contact Information:
N/A
Study Complete
Study Details
Medical Condition
- Other
Study Drug
- Drug: ALXN1840 Enteric-coated Tablet
- Drug: ALXN1840 Non-coated Capsule
- Drug: Omeprazole
Date
Apr 2014 - May 2014
Phase 1
Phase 2
Phase 3
Phase 4
N/A
Patient Requirements
Sex: Female & Male
Age: 19 - 55 Years
Requirements Information
Sex
Female & Male
Age
19 - 55 Years
Study Details
Medical Condition
- Other
Study Drug
- Drug: ALXN1840 Enteric-coated Tablet
- Drug: ALXN1840 Non-coated Capsule
- Drug: Omeprazole
Date
Apr 2014 - May 2014
Phase 1
Phase 2
Phase 3
Phase 4
N/A
Patient Requirements
Sex: Female & Male
Age: 19 - 55 Years years
Requirements Information
Protocol Summary
This was single-center, open-label, randomized, 3-period, 3-treatment, 6-sequence crossover study evaluating the PK of single doses of WTX101 in healthy participants based on the measurement of plasma total Mo concentration.
Trial Locations
Location
Status
Location
Clinical Trial Site
Lincoln, Nebraska, United States, 68502
Status
N/A